James H. Sabry

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

James H. Sabry

James H. Sabry

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Overview
Career Highlights

Cytokinetics, Inc.
Arête Therapeutics, Inc.

RelSci Relationships

5379

Number of Boards

7

Birthday

12/1958

Age

62

Relationships
RelSci Relationships are individuals James H. Sabry likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Roche Holding AG

Relationship likelihood: Strong

Chairman & Chief Executive Officer of Chugai at Roche Holding AG

Relationship likelihood: Strong

Head-Group Human Resources at Roche Holding AG

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Cytokinetics, Inc.

Relationship likelihood: Strong

Relationship likelihood: Strong

Chief Financial & Information Technology Officer at Roche Holding AG

Relationship likelihood: Strong

Chief Executive Officer at Roche Ventures

Relationship likelihood: Strong

Relationship likelihood: Strong

Secretary-Executive Committee & Head-Chief Executive Officer Office at Roche Holding AG

Relationship likelihood: Strong

Vice Chairman at ScienceIndustries

Relationship likelihood: Strong

Paths to James H. Sabry
Potential Connections via
Relationship Science
You
James H. Sabry
Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG
Education
MD

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

PhD in Cell Biology

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Memberships
Member
Current

YPO (Young Presidents’ Organization) connects people with successful young chief executives in a global network unlike any other. Founded in 1950 in New York City by a young president named Ray Hickok, the organization unites approximately 20,000 business leaders in more than 120 countries around a shared mission: Better Leaders Through Education and Idea Exchange. A great deal has changed since YPO’s founding but certain things have remained the same: the value of a peer network and trusted mentors, the importance of ongoing education, and the need for a “safe haven” where issues can be aired in an environment of confidentiality. Over the past six decades, YPO has maintained its core commitment to these ideals while embracing change with each successive generation of young business leaders.

Member
Current

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology.American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Member
Current

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Career History
Global Head of Partnering
2018 - Current

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering
Current

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

President & Chief Executive Officer, Director
1997 - 2010

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Boards & Committees
Member, Board of Directors
2019 - Current

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Member, Enlarged Corporate Executive Committee
2018 - Current

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Member, Board of Directors
2015 - Current

California Biomedical Innovation Alliance is an American private company located in South San Francisco, CA, with operations in the United States. The firm provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the company.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

Board Member
2006 - ?

HopeLab Foundation is a non-profit organization that develops technology-based products to improve human health and well-being. Its products include Mitra App, Greater Good in Action, Mood Meter App, Re-Mission 2, Zamzee, Resilience Initiative, Re-Mission, Ruckus Nation, and Digital Storytelling Workshop. The company was founded by Pam Omidyar in 2001 and is headquartered in Redwood City, CA.

Director
Tenure Unconfirmed

California Life Sciences Association is an American nonprofit company located in South San Francisco, CA, that acts as a trade association which represents the life sciences industry of California. Mike Guerra is the current CEO, occupying that position since 2019.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State.

Director
Tenure Unconfirmed

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 +
2014

ASCB IS AN INCLUSIVE, INTERNATIONAL COMMUNITY OF BIOLOGISTS STUDYING THE CELL, THE FUNDAMENTAL UNIT OF LIFE. WE ARE DEDICATED TO ADVANCING SCIENTIFIC DISCOVERY, ADVOCATING SOUND RESEARCH POLICIES, IMPROVING EDUCATION, PROMOTING PROFESSIONAL DEVELOPMENT, AND INCREASING DIVERSITY AND INCLUSIVITY IN THE SCIENTIFIC WORKFORCE.

Investments
Details Hidden

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James H. Sabry. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James H. Sabry's profile does not indicate a business or promotional relationship of any kind between RelSci and James H. Sabry.